Aerovate Therapeutics
AVTE
#5850
Rank
$0.59 B
Marketcap
$20.57
Share price
-6.12%
Change (1 day)
7.30%
Change (1 year)

Aerovate Therapeutics (AVTE) - Net assets

Net assets on the balance sheet as of December 2023 : $0.10 B

According to Aerovate Therapeutics's latest financial reports the company has $0.10 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Aerovate Therapeutics - Net assets on balance sheet (from 2020 to 2023)

Net assets by year

Year Net assets Change
2022-12-31$0.12 B-26.49%
2021-12-31$0.17 B-1392.1%
2020-12-31$-13.35 M266.29%
2019-12-31$-3.65 M